MYD88 and lymphoma: In a similar work, Zorofchian et al. applied again ddPCR to detect MYD88 mutations (L265P and V217F) in isolated cerebrospinal fluid (CSF)-circulating tumor DNA (ctDNA), in conjunction with evaluating the patient-matched central nervous system (CNS) lymphoma tissue [68].